Search results for 'Sun Pharmaceutical'

Trump 2.0: Tough Navigation Lies Ahead For India

Trump 2.0: Tough Navigation Lies Ahead For India

Rediff.com12 Feb 2025

'As the global economy undergoes significant transformations in 2025, India's ability to navigate the complexities of trade wars, financial realignments, and emerging blocs will be pivotal,' explain Harsh V Pant and Soumya Bhowmik.

How Tamil Nadu Is Becoming A Global Hub

How Tamil Nadu Is Becoming A Global Hub

Rediff.com2 Apr 2025

After Chennai, it is Coimbatore, Madurai, and Tiruchirappalli, that are emerging as manufacturing hubs. Coimbatore is India's top Tier-II city in terms of the number of GCCs, according to a report by Cushman & Wakefield.

EXPLAINED: Trump's reciprocal tariffs

EXPLAINED: Trump's reciprocal tariffs

Rediff.com3 Apr 2025

Here is a list of Q & As to explain these issues and implications of the US move.

Trump tariffs: 'This is not a tax cut, this is a tax hike'

Trump tariffs: 'This is not a tax cut, this is a tax hike'

Rediff.com3 Apr 2025

"These latest so-called 'Liberation Day' tariffs are reckless and self-destructive, inflicting financial pain on Illinois at a time when people are already struggling to keep their small businesses afloat and put food on the table."

Selling in HDFC Bank, RIL drag markets down

Selling in HDFC Bank, RIL drag markets down

Rediff.com3 Mar 2025

From the Sensex pack, Reliance Industries, Bajaj Finserv, HDFC Bank, Adani Ports, Maruti Suzuki India, Axis Bank, Hindustan Unilever, Sun Pharmaceuticals and Asian Paints were among the laggards. Reliance Industries fell the most by 2.38 per cent to close at Rs 1,171.10 apiece.

How To Apply For A Rs 1 Lakh MBBS Scholarship

How To Apply For A Rs 1 Lakh MBBS Scholarship

Rediff.com20 Nov 2024

Under this scholarship, first-year MBBS students from government colleges are eligible to receive monetary assistance of up to Rs 1,00,000 per year for a duration of up to 4.5 years, covering academic expenses incurred towards their MBBS degree.

There will be some pain: Trump's message to Americans

There will be some pain: Trump's message to Americans

Rediff.com3 Feb 2025

United States President Donald Trump on Sunday criticised the trade deficits that the US has with Canada, Mexico, China, and argued that America should no longer 'subsidise' other countries, and urged businesses to manufacture domestically to avoid tariffs.

Two Indian students killed in car crash in Ireland; 2 critical

Two Indian students killed in car crash in Ireland; 2 critical

Rediff.com2 Feb 2025

Two Indian students in their 20s were killed and two others injured in a car crash in County Carlow, southern Ireland. The Indian Embassy in Dublin issued a condolence message on social media. The four friends had been sharing a house in the local area and had recently finished third-level education at South East Technological University (SETU) in Carlow.

Factors that will support credit access of India Inc in FY26

Factors that will support credit access of India Inc in FY26

Rediff.com13 Jan 2025

Fitch Ratings on Monday said India's steady GDP growth outlook, improved banking sector's financial health and expected interest-rate cuts in 2025 will support credit access for corporates in FY26.

Budget focuses on domestic consumption amid global uncertainties

Budget focuses on domestic consumption amid global uncertainties

Rediff.com4 Feb 2025

The Budget 2025-26 meets the expectations of fiscal consolidation, maintaining capital expenditure, and boosting consumption through tax cuts.

'Trump's Hopes For India's Tariff Cuts Too Ambitious'

'Trump's Hopes For India's Tariff Cuts Too Ambitious'

Rediff.com2 Apr 2025

'I certainly hope the two can avoid a trade war and believe they will.' 'I expect some in India will push for retaliatory tariffs if the Trump administration applies significant reciprocal tariffs.'

Have Indian DNA, many of us have Sanskrit names: Indonesian Prez

Have Indian DNA, many of us have Sanskrit names: Indonesian Prez

Rediff.com27 Jan 2025

'Everybody knows when I hear Indian music, I start dancing'

Modi 3.0's Plans For Ayushman Bharat

Modi 3.0's Plans For Ayushman Bharat

Rediff.com12 Jun 2024

The Centre is considering a proposal on increasing coverage under the Ayushman Bharat scheme to Rs 10 lakh from the current Rs 5 lakh.

Trump vows tariffs on nations that 'harm' US; names India, China

Trump vows tariffs on nations that 'harm' US; names India, China

Rediff.com28 Jan 2025

Earlier, Trump has already talked about slapping "100 per cent tariffs" on the BRICS grouping, a bloc that includes India as well.

Oscar-Nominated Movies Rule OTT

Oscar-Nominated Movies Rule OTT

Rediff.com28 Feb 2025

Women power, rebellious love, shady godmen, love triangles and more on OTT. Sukanya Verma lists everything coming up on OTT this week.

Trump's 'America First' agenda may lead to higher tariffs

Trump's 'America First' agenda may lead to higher tariffs

Rediff.com6 Nov 2024

With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue the 'America First' agenda, opined trade experts. Experts also said that Trump could also tighten H-1B visa rules, impacting costs and growth for Indian IT firms. Over 80 per cent of India's IT export earnings come from the US, making it vulnerable to changes in visa policies.

US pledges to boost technology ties with India

US pledges to boost technology ties with India

Rediff.com14 Feb 2025

Artificial Intelligence, innovation and next-generation technologies figured prominently during the high-stakes discussion between Prime Minister Narendra Modi and US President Donald Trump at the White House, as the two sides announced transformative measures, including the US-India TRUST initiative, roadmap on accelerating AI infrastructure and INDUS Innovation, to boost tech ties.

'US May Demand Not Just Tariff Cuts But...'

'US May Demand Not Just Tariff Cuts But...'

Rediff.com5 Mar 2025

I'...additional concessions, such as opening government procurement, reducing agricultural subsidies, weakening patent protections, and allowing unrestricted data flows -- demands India has resisted for decades.'

FDI inflows in India cross $1 trillion

FDI inflows in India cross $1 trillion

Rediff.com8 Dec 2024

Foreign direct investment (FDI) inflows into India have crossed the $1 trillion milestone in the April 2000-September 2024 period, firmly establishing the country's reputation as a safe and key investment destination globally. According to data from the Department for Promotion of Industry and Internal Trade (DPIIT), the cumulative amount of FDI, including equity, reinvested earnings and other capital, stood at $1,033.40 billion during the said period.

BSE 100 companies boost R&D, innovation challenges persist

BSE 100 companies boost R&D, innovation challenges persist

Rediff.com13 Oct 2024

Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period in-between, according to data compiled from Bloomberg and company annual reports. Also, these companies more than doubled their R&D spending in absolute terms over these five years: From Rs 25,041 crore to Rs 63,072 crore. While this reflects a prioritisation of innovation, corporate R&D investment remains relatively conservative.

Secondary Market Saw Lacklustre Funding In 2024

Secondary Market Saw Lacklustre Funding In 2024

Rediff.com7 Jan 2025

Net flows from domestic institutional investors crossed Rs 5 trillion for the first time during a calendar year.

Indian pharmaceutical M&As see unhealthy decline

Indian pharmaceutical M&As see unhealthy decline

Rediff.com4 Apr 2008

While the April to September period (H1) saw as many as eight major deals worth over Rs 5,000 crore (Rs 50 billion), the second half of the year saw a sharp drop in the value of such deals to about Rs 1,500 crore (Rs 15 billion). Though the number of deals in H1 and H2 is almost the same, the sharp decline in value in the second half indicates a clear change in outlook and strategy of companies, say industry experts.

Women, Your Birth Number Can Help You Succeed

Women, Your Birth Number Can Help You Succeed

Rediff.com7 Mar 2025

By understanding the elements that rule your birth number, you can learn how to enhance your professional journey, improve your work life and grow in your career.

Lower input costs may aid pharma firms' Q2 margins

Lower input costs may aid pharma firms' Q2 margins

Rediff.com21 Oct 2024

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.

Who Are India's Newest Billionaires?

Who Are India's Newest Billionaires?

Rediff.com11 Oct 2024

The collective wealth of the 100 richest went past $1 trillion for the first time.

India Inc profits crawl as sales stay sluggish

India Inc profits crawl as sales stay sluggish

Rediff.com24 Feb 2025

Corporate India's struggle with subdued revenue and earnings growth persisted in the October-December quarter of 2024-25 (Q3FY25). The combined net sales (gross interest earnings for lenders) of listed companies grew in single digits for the seventh consecutive quarter, while their combined net profit rose by a single digit for the third straight quarter.

Rupee depreciation may exacerbate market sell-off if downtrend continues

Rupee depreciation may exacerbate market sell-off if downtrend continues

Rediff.com21 Jan 2025

Rupee depreciation, if it continues, will likely pull the markets down further. Since September 2024, the rupee has declined by 3.1 per cent, the Nifty has dropped by 8.5 per cent during the same period, and the Sensex has fallen by 7.3 per cent. If the decline continues, markets will need to brace for more pain as it could push foreign portfolio investors (FPIs) to exit their positions faster than anticipated.

Budget 2025: What is costlier, what is cheaper

Budget 2025: What is costlier, what is cheaper

Rediff.com2 Feb 2025

Here is a list of items set to become cheaper and costlier.

Dabba Cartel Review: High Five!

Dabba Cartel Review: High Five!

Rediff.com28 Feb 2025

Dabba Cartel's reluctant black comedy in the body of a crime thriller starts out interestingly enough to accomplish its Narcos: Thane aspirations, notes Sukanya Verma.

India's exports down 1% to $38.01 bn in Dec

India's exports down 1% to $38.01 bn in Dec

Rediff.com15 Jan 2025

India's merchandise exports dipped by about one per cent to $38.01 billion in December 2024 against $38.39 billion a year ago, according to government data released on Wednesday. Imports increased by 4.8 per cent to $59.95 billion in December 2024 compared to $57.15 billion in the year-ago month.

10 Stocks That Soared While Market Sank

10 Stocks That Soared While Market Sank

Rediff.com24 Mar 2025

The stocks are largely from sectors such as chemicals, finance and cement, which struggled earlier but the worse seems to be behind them.

Young Indian Leaders Shine at WEF 2025

Young Indian Leaders Shine at WEF 2025

Rediff.com23 Jan 2025

Barring a few, such as Andhra Pradesh Chief Minister N Chandrababu Naidu (74), Union Minister C R Patil (69) and Uttar Pradesh Finance Minister Suresh Khanna (71), most other ministers attending the WEF represent the next generation of India's politicians.

Want To Invest In Pharma & Healthcare?

Want To Invest In Pharma & Healthcare?

Rediff.com5 Nov 2024

'A long-term investor with a 4 to 5 year horizon could invest in this theme via SIPs.'

Trump's Reciprocal Tariffs Bite Into Apple's India Growth Plans

Trump's Reciprocal Tariffs Bite Into Apple's India Growth Plans

Rediff.com12 Mar 2025

Apple's ambitious strategy to expand iPhone exports, shift more production from China to India at a faster pace, and grow its domestic market hits a Trump-sized roadblock.

5% Reduction in Tax Can Stimulate Spending

5% Reduction in Tax Can Stimulate Spending

Rediff.com31 Jan 2025

While this will incur a revenue loss amounting to 0.2 per cent of GDP, it will provide a strong boost to consumer sentiment and spending, points out Rajani Sinha.

'Tariffs will hurt insurance, patients and everyone'

'Tariffs will hurt insurance, patients and everyone'

Rediff.com10 Feb 2025

After registering a net profit of Rs 25.1 crore in Q3FY25 and consolidated revenues growing by 7 per cent on a like-for-like basis, Siddharth Mittal, chief executive officer (CEO) and managing director, Biocon, told Sohini Das/Business Standard in a virtual interaction that local manufacturing in the US is a trade off between cost and qualifying to do business there.

Mutual funds increase exposure to banking, IT stocks amid outperformance

Mutual funds increase exposure to banking, IT stocks amid outperformance

Rediff.com19 Dec 2024

The performance of banking and information technology (IT) stocks has had a significant impact on the composition of diversified mutual fund (MF) portfolios. Over the past two months, these sectors have become increasingly dominant, now constituting nearly 30 per cent of the total allocation in many diversified MF portfolios.

Budget Prepares For Rise In Cancer Cases

Budget Prepares For Rise In Cancer Cases

Rediff.com3 Feb 2025

Do we have enough trained oncologists and medical professionals in India to man these over 4,500 beds in the public sector?

618 Drugs 'Not Of Standard Quality'

618 Drugs 'Not Of Standard Quality'

Rediff.com9 Dec 2024

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid. Medications using these combinations are commonly used to treat fever, mild migraine, period and muscle pain.

Centre bans 156 drugs used for fever, pain, allergies

Centre bans 156 drugs used for fever, pain, allergies

Rediff.com22 Aug 2024

FDC drugs are those which contain a combination of two or more active pharmaceutical ingredients in a fixed ratio and are also referred to as 'cocktail' drugs.